Antiretroviral therapy coverage in Comoros
Comoros: Antiretroviral therapy coverage was 84.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Comoros, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Comoros is 84.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 23.5% on the previous year and up 250.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Comoros peaked at 84.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Comoros 41st out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Comoros, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 17.0% | — |
| 2011 | 18.0% | +5.9% |
| 2012 | 21.0% | +16.7% |
| 2013 | 23.0% | +9.5% |
| 2014 | 24.0% | +4.3% |
| 2015 | 31.0% | +29.2% |
| 2016 | 34.0% | +9.7% |
| 2017 | 37.0% | +8.8% |
| 2018 | 43.0% | +16.2% |
| 2019 | 54.0% | +25.6% |
| 2020 | 57.0% | +5.6% |
| 2021 | 58.0% | +1.8% |
| 2022 | 62.0% | +6.9% |
| 2023 | 68.0% | +9.7% |
| 2024 | 84.0% | +23.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 30.2% | 17.0% | 54.0% | 10 |
| 2020s | 65.8% | 57.0% | 84.0% | 5 |
Countries ranked near Comoros
- 39 Croatia 85.0% compare
- 39 Uganda 85.0% compare
- 41 Luxembourg 84.0% compare
- 41 New Zealand 84.0% compare
- 44 Nigeria 83.0% compare
More health data for Comoros
- Un projection of annual infant deaths, annual growth rate -2.16 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8656 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 827.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 136 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.6648 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0647 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.6855 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Comoros?
- Antiretroviral therapy coverage in Comoros was 84.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Comoros?
- The highest recorded value was 84.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Comoros?
- The lowest recorded value was 0.0% in 2000.
- How does Comoros rank for antiretroviral therapy coverage?
- Comoros ranks 41st out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Comoros?
- Over the last ten years it is up 250.0%. The long-run trend across the full record is volatile.
- Where does this Comoros data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.